1. Home
  2. KC vs STVN Comparison

KC vs STVN Comparison

Compare KC & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kingsoft Cloud Holdings Limited

KC

Kingsoft Cloud Holdings Limited

HOLD

Current Price

$13.88

Market Cap

3.8B

Sector

Technology

ML Signal

HOLD

Logo Stevanato Group S.p.A.

STVN

Stevanato Group S.p.A.

HOLD

Current Price

$14.06

Market Cap

4.0B

ML Signal

HOLD

Company Overview

Basic Information
Metric
KC
STVN
Founded
2012
1949
Country
China
Italy
Employees
13868
N/A
Industry
Computer Software: Prepackaged Software
Containers/Packaging
Sector
Technology
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
3.8B
4.0B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
KC
STVN
Price
$13.88
$14.06
Analyst Decision
Strong Buy
Buy
Analyst Count
3
3
Target Price
$18.00
$25.67
AVG Volume (30 Days)
1.5M
535.1K
Earning Date
03-25-2026
03-04-2026
Dividend Yield
N/A
0.45%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$20.62
$9.67
Revenue Next Year
$17.55
$9.99
P/E Ratio
N/A
$27.15
Revenue Growth
N/A
N/A
52 Week Low
$10.29
$12.89
52 Week High
$17.79
$28.00

Technical Indicators

Market Signals
Indicator
KC
STVN
Relative Strength Index (RSI) 52.20 40.86
Support Level $12.98 N/A
Resistance Level $15.20 $16.69
Average True Range (ATR) 0.67 0.64
MACD -0.04 -0.05
Stochastic Oscillator 42.16 39.82

Price Performance

Historical Comparison
KC
STVN

About KC Kingsoft Cloud Holdings Limited

Kingsoft Cloud Holdings Ltd is an independent cloud service provider in China. It provides integrated cloud-based services including cloud computing, storage, and delivery. Its products and services are Security, Database, Data Analysis, Networking, and others. Its solutions are medical, government affairs, finance, media, education, gaming, Vehicle solutions, and others.

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, It derives its majority revenue from Europe, Middle East and Africa.

Share on Social Networks: